Pharmaids Pharmaceuticals Ltd.
Snapshot View

13.70 +0.19 ▲1.4%

23 September 2022, 04:00:00 PM
Volume: 9,159

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pharmaids.com
Market Cap 13.93 Cr.
Enterprise Value(EV) 13.72 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -0.05 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 30.97 Trailing Twelve Months Ending 2022-06
Book Value / Share 8.31 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.63 Calculated using Price: 13.51
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.03 Cr. 10,311,234 Shares
FaceValue 10
Company Profile
The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.41%
1 Week
1 Month
+5.63%
3 Month
+23.42%
6 Month
1 Year
-3.52%
2 Year
+129.48%
5 Year
+352.15%
10 Year
+328.12%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -17.79 -3.71 -26.21 7.99 -31.24 -3.76 0.40 1.10 1.69
Return on Capital Employed (%) -14.96 -4.99 -21.19 7.61 -29.73 -3.02 -4.45 1.04 1.66
Return on Assets (%) -11.66 -2.42 -16.50 5.08 -23.27 -3.56 0.40 1.11 1.49

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 2 2 2 1 1 1 8 8 9 9
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 1 1 1 1 0 0 0 1 2
Minority Int.
Equity & Liab. 3 3 3 2 2 1 9 8 9 11
Non Curr. Assets 1 1 1 1 0 1 4 8 8 8
Curr. Assets 2 2 2 2 2 1 4 0 1 3
Misc. Exp. not W/O
Total Assets 3 3 3 2 2 1 9 8 9 11

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1 2 2 1 0 1 9 4 2
Other Income 0 0 0 0 0 0 0 0 0
Total Income 2 2 2 1 0 1 9 4 2
Total Expenditure -2 -2 -2 -2 -1 -1 0 -8 -4 -2
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0
Exceptional Items 1
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS -1 0 -1 0 -1 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 -1 0 0
Cash Fr. Inv. 0 0 0 0 1 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 1 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 2.19 65.90 65.84 65.81 65.80 65.65 55.56 35.44 20.70
Public 97.81 34.10 34.16 34.19 34.20 34.35 44.44 64.56 79.30
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 23 Aug 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Pharmaids Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here
Mon, 22 Aug 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Dear Sir/Madam This is to inform that 33rd Annual General Meeting (AGM) of the Company was conducted on August 20 2022 at 12:00 P.M. through Video Conferencing (VC) and/or Other Audio Visual Means (OVAM) in compliance with the Companies Act SEBI (LODR) Regulations Secretarial Standards and various circulars issued by MCA in connection with conducting AGM through VC or OVAM.In this regard Please find enclosed the following:1. Disclosure of Voting results in terms of Regulation 44(3) of SEBI (LODR) Regulations.2. Scrutinizers report by Mr. Kashinath Sahu Practicing Company Secretary.All the resolutions mentioned in the notice of AGM were passed unanimously.This is for your information and for dissemination to general public.For Pharmaids Pharmaceuticals LimitedAnnie JodhaniCompany Secretary & Compliance Officer
Sat, 20 Aug 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 33rd AGM

Technical Scans View Details >>

Fri, 23 Sep 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase 3 Months High Increase 3 Months
High Increase 2 Years High Increase 2 Years
High Increase 5 Years High Increase 5 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,930.76 920.80 +1.5%
Divi's Laboratories Ltd. 96,681.00 3,641.90 +1.7%
Cipla Ltd. 86,429.87 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. 68,908.63 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. 63,570.07 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. 51,257.56 1,514.50 -1.6%
Max Healthcare Institute Ltd. 41,385.83 426.80 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.80 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.13 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 34.73 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.04 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.96 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.99 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 65.59 426.80 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.41 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.78 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 4.02 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.70 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.02 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.43 426.80 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 426.80 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 426.80 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 426.80 -0.1%

FAQ's On Pharmaids Pharmaceuticals Ltd.

What is Pharmaids Pharma share price?

Can I buy Pharmaids Pharma shares now?

What is the Market Cap of Pharmaids Pharma?

What are the key metrics to analyse Pharmaids Pharma?

What is the 52 Week High and Low of Pharmaids Pharma?

What is the trend of Pharmaids Pharma share price?